Indium (111In) imciromab
| Monoclonal antibody | |
|---|---|
| Type | Fab fragment |
| Source | Mouse |
| Target | cardiac myosin |
| Clinical data | |
| Trade names | Myoscint |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number |
|
| ChemSpider |
|
| UNII | |
  (what is this?) (verify) | |
Indium (111In) imciromab (trade name Myoscint) is a mouse monoclonal antibody labelled with the radioisotope Indium-111.[1] It was used for cardiac imaging, but withdrawn in 1993.[2]
See also
[edit]References
[edit]- ^ WHO Drug Information
- ^ "DiagnosticImaging.com: Centocor withdraws imaging agent applications". Archived from the original on 2012-02-26. Retrieved 2009-10-17.
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
 | This nuclear medicine article is a stub. You can help Wikipedia by expanding it. |